English
简体中文
Total: £ 56.28
Published Date: 2026-01-22 | Pages: 133 | Tables: 134 | Medical Care
The global New Chemical Entities (NCE) market was valued at US$ 4992 million in 2025 and is anticipated to reach US$ 10420 million by 2032, at a CAGR of 11.2% from 2026 to 2032.
During the drug discovery process, new compounds or active moieties (molecules or ions responsible for physiological or pharmacological action) can arise that have not previously been FDA-approved. These compounds are called New Chemical Entities (NCE) as they have not previously been used, and they can help bring about cures and therapies for incurable diseases such as cancer due to the novelty of the drug and or compound.In the existing market, there are already companies providing CDMO services for new chemical entities, and there are also companies providing new chemical entity discovery services, which can then be handed over to other companies for drug development.
The North American market for New Chemical Entities (NCE) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for New Chemical Entities (NCE) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for New Chemical Entities (NCE) in Tumors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of New Chemical Entities (NCE) include KATSURA CHEMICAL CO., LTD, NMS Group (Accelera Srl), Adragos Pharma, Syngene, Regis Custom API, Bachem, Suven Pharma, Aspen API, MedPharm, Intertek, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global New Chemical Entities (NCE) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding New Chemical Entities (NCE). The New Chemical Entities (NCE) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global New Chemical Entities (NCE) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist New Chemical Entities (NCE) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
KATSURA CHEMICAL CO., LTD
NMS Group (Accelera Srl)
Adragos Pharma
Syngene
Regis Custom API
Bachem
Suven Pharma
Aspen API
MedPharm
Intertek
Neuland Laboratories
Piramal Pharma Solutions
Sai Life Sciences
Chempro Pharma
LG Chem
Sofpromed
Aurigene Pharmaceutical Services Ltd.
Aragen Life Sciences Ltd
WuXi AppTec
PharmaBlock Sciences Nanjing Inc
Segment by Type
NCE Discovery
Drug Formulation Development
Large-scale Manufacturing
Segment by Application
Tumors
Cardiovascular Diseases
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for New Chemical Entities (NCE) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Chemical Entities (NCE) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 NCE Discovery
1.2.3 Drug Formulation Development
1.2.4 Large-scale Manufacturing
1.3 Market by Application
1.3.1 Global New Chemical Entities (NCE) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Tumors
1.3.3 Cardiovascular Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Chemical Entities (NCE) Market Perspective (2021–2032)
2.2 Global New Chemical Entities (NCE) Growth Trends by Region
2.2.1 Global New Chemical Entities (NCE) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 New Chemical Entities (NCE) Historic Market Size by Region (2021–2026)
2.2.3 New Chemical Entities (NCE) Forecasted Market Size by Region (2027–2032)
2.3 New Chemical Entities (NCE) Market Dynamics
2.3.1 New Chemical Entities (NCE) Industry Trends
2.3.2 New Chemical Entities (NCE) Market Drivers
2.3.3 New Chemical Entities (NCE) Market Challenges
2.3.4 New Chemical Entities (NCE) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Chemical Entities (NCE) Players by Revenue
3.1.1 Global Top New Chemical Entities (NCE) Players by Revenue (2021–2026)
3.1.2 Global New Chemical Entities (NCE) Revenue Market Share by Players (2021–2026)
3.2 Global Top New Chemical Entities (NCE) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by New Chemical Entities (NCE) Revenue
3.4 Global New Chemical Entities (NCE) Market Concentration Ratio
3.4.1 Global New Chemical Entities (NCE) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Chemical Entities (NCE) Revenue in 2025
3.5 Global Key Players of New Chemical Entities (NCE) Head Offices and Areas Served
3.6 Global Key Players of New Chemical Entities (NCE), Products and Applications
3.7 Global Key Players of New Chemical Entities (NCE), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 New Chemical Entities (NCE) Breakdown Data by Type
4.1 Global New Chemical Entities (NCE) Historic Market Size by Type (2021–2026)
4.2 Global New Chemical Entities (NCE) Forecasted Market Size by Type (2027–2032)
5 New Chemical Entities (NCE) Breakdown Data by Application
5.1 Global New Chemical Entities (NCE) Historic Market Size by Application (2021–2026)
5.2 Global New Chemical Entities (NCE) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America New Chemical Entities (NCE) Market Size (2021–2032)
6.2 North America New Chemical Entities (NCE) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America New Chemical Entities (NCE) Market Size by Country (2021–2026)
6.4 North America New Chemical Entities (NCE) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Chemical Entities (NCE) Market Size (2021–2032)
7.2 Europe New Chemical Entities (NCE) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe New Chemical Entities (NCE) Market Size by Country (2021–2026)
7.4 Europe New Chemical Entities (NCE) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific New Chemical Entities (NCE) Market Size (2021–2032)
8.2 Asia-Pacific New Chemical Entities (NCE) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific New Chemical Entities (NCE) Market Size by Region (2021–2026)
8.4 Asia-Pacific New Chemical Entities (NCE) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America New Chemical Entities (NCE) Market Size (2021–2032)
9.2 Latin America New Chemical Entities (NCE) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America New Chemical Entities (NCE) Market Size by Country (2021–2026)
9.4 Latin America New Chemical Entities (NCE) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Chemical Entities (NCE) Market Size (2021–2032)
10.2 Middle East & Africa New Chemical Entities (NCE) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa New Chemical Entities (NCE) Market Size by Country (2021–2026)
10.4 Middle East & Africa New Chemical Entities (NCE) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 KATSURA CHEMICAL CO., LTD
11.1.1 KATSURA CHEMICAL CO., LTD Company Details
11.1.2 KATSURA CHEMICAL CO., LTD Business Overview
11.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) Introduction
11.1.4 KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.1.5 KATSURA CHEMICAL CO., LTD Recent Development
11.2 NMS Group (Accelera Srl)
11.2.1 NMS Group (Accelera Srl) Company Details
11.2.2 NMS Group (Accelera Srl) Business Overview
11.2.3 NMS Group (Accelera Srl) New Chemical Entities (NCE) Introduction
11.2.4 NMS Group (Accelera Srl) Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.2.5 NMS Group (Accelera Srl) Recent Development
11.3 Adragos Pharma
11.3.1 Adragos Pharma Company Details
11.3.2 Adragos Pharma Business Overview
11.3.3 Adragos Pharma New Chemical Entities (NCE) Introduction
11.3.4 Adragos Pharma Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.3.5 Adragos Pharma Recent Development
11.4 Syngene
11.4.1 Syngene Company Details
11.4.2 Syngene Business Overview
11.4.3 Syngene New Chemical Entities (NCE) Introduction
11.4.4 Syngene Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.4.5 Syngene Recent Development
11.5 Regis Custom API
11.5.1 Regis Custom API Company Details
11.5.2 Regis Custom API Business Overview
11.5.3 Regis Custom API New Chemical Entities (NCE) Introduction
11.5.4 Regis Custom API Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.5.5 Regis Custom API Recent Development
11.6 Bachem
11.6.1 Bachem Company Details
11.6.2 Bachem Business Overview
11.6.3 Bachem New Chemical Entities (NCE) Introduction
11.6.4 Bachem Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.6.5 Bachem Recent Development
11.7 Suven Pharma
11.7.1 Suven Pharma Company Details
11.7.2 Suven Pharma Business Overview
11.7.3 Suven Pharma New Chemical Entities (NCE) Introduction
11.7.4 Suven Pharma Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.7.5 Suven Pharma Recent Development
11.8 Aspen API
11.8.1 Aspen API Company Details
11.8.2 Aspen API Business Overview
11.8.3 Aspen API New Chemical Entities (NCE) Introduction
11.8.4 Aspen API Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.8.5 Aspen API Recent Development
11.9 MedPharm
11.9.1 MedPharm Company Details
11.9.2 MedPharm Business Overview
11.9.3 MedPharm New Chemical Entities (NCE) Introduction
11.9.4 MedPharm Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.9.5 MedPharm Recent Development
11.10 Intertek
11.10.1 Intertek Company Details
11.10.2 Intertek Business Overview
11.10.3 Intertek New Chemical Entities (NCE) Introduction
11.10.4 Intertek Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.10.5 Intertek Recent Development
11.11 Neuland Laboratories
11.11.1 Neuland Laboratories Company Details
11.11.2 Neuland Laboratories Business Overview
11.11.3 Neuland Laboratories New Chemical Entities (NCE) Introduction
11.11.4 Neuland Laboratories Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.11.5 Neuland Laboratories Recent Development
11.12 Piramal Pharma Solutions
11.12.1 Piramal Pharma Solutions Company Details
11.12.2 Piramal Pharma Solutions Business Overview
11.12.3 Piramal Pharma Solutions New Chemical Entities (NCE) Introduction
11.12.4 Piramal Pharma Solutions Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.12.5 Piramal Pharma Solutions Recent Development
11.13 Sai Life Sciences
11.13.1 Sai Life Sciences Company Details
11.13.2 Sai Life Sciences Business Overview
11.13.3 Sai Life Sciences New Chemical Entities (NCE) Introduction
11.13.4 Sai Life Sciences Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.13.5 Sai Life Sciences Recent Development
11.14 Chempro Pharma
11.14.1 Chempro Pharma Company Details
11.14.2 Chempro Pharma Business Overview
11.14.3 Chempro Pharma New Chemical Entities (NCE) Introduction
11.14.4 Chempro Pharma Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.14.5 Chempro Pharma Recent Development
11.15 LG Chem
11.15.1 LG Chem Company Details
11.15.2 LG Chem Business Overview
11.15.3 LG Chem New Chemical Entities (NCE) Introduction
11.15.4 LG Chem Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.15.5 LG Chem Recent Development
11.16 Sofpromed
11.16.1 Sofpromed Company Details
11.16.2 Sofpromed Business Overview
11.16.3 Sofpromed New Chemical Entities (NCE) Introduction
11.16.4 Sofpromed Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.16.5 Sofpromed Recent Development
11.17 Aurigene Pharmaceutical Services Ltd.
11.17.1 Aurigene Pharmaceutical Services Ltd. Company Details
11.17.2 Aurigene Pharmaceutical Services Ltd. Business Overview
11.17.3 Aurigene Pharmaceutical Services Ltd. New Chemical Entities (NCE) Introduction
11.17.4 Aurigene Pharmaceutical Services Ltd. Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.17.5 Aurigene Pharmaceutical Services Ltd. Recent Development
11.18 Aragen Life Sciences Ltd
11.18.1 Aragen Life Sciences Ltd Company Details
11.18.2 Aragen Life Sciences Ltd Business Overview
11.18.3 Aragen Life Sciences Ltd New Chemical Entities (NCE) Introduction
11.18.4 Aragen Life Sciences Ltd Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.18.5 Aragen Life Sciences Ltd Recent Development
11.19 WuXi AppTec
11.19.1 WuXi AppTec Company Details
11.19.2 WuXi AppTec Business Overview
11.19.3 WuXi AppTec New Chemical Entities (NCE) Introduction
11.19.4 WuXi AppTec Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.19.5 WuXi AppTec Recent Development
11.20 PharmaBlock Sciences Nanjing Inc
11.20.1 PharmaBlock Sciences Nanjing Inc Company Details
11.20.2 PharmaBlock Sciences Nanjing Inc Business Overview
11.20.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) Introduction
11.20.4 PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.20.5 PharmaBlock Sciences Nanjing Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global New Chemical Entities (NCE) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of NCE Discovery
Table 3. Key Players of Drug Formulation Development
Table 4. Key Players of Large-scale Manufacturing
Table 5. Global New Chemical Entities (NCE) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global New Chemical Entities (NCE) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global New Chemical Entities (NCE) Market Size by Region (US$ Million), 2021–2026
Table 8. Global New Chemical Entities (NCE) Market Share by Region (2021–2026)
Table 9. Global New Chemical Entities (NCE) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global New Chemical Entities (NCE) Market Share by Region (2027–2032)
Table 11. New Chemical Entities (NCE) Market Trends
Table 12. New Chemical Entities (NCE) Market Drivers
Table 13. New Chemical Entities (NCE) Market Challenges
Table 14. New Chemical Entities (NCE) Market Restraints
Table 15. Global New Chemical Entities (NCE) Revenue by Players (US$ Million), 2021–2026
Table 16. Global New Chemical Entities (NCE) Market Share by Players (2021–2026)
Table 17. Global Top New Chemical Entities (NCE) Players by Tier (Tier 1, Tier 2, and Tier 3), based on New Chemical Entities (NCE) Revenue, 2025
Table 18. Ranking of Global Top New Chemical Entities (NCE) Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by New Chemical Entities (NCE) Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of New Chemical Entities (NCE), Headquarters and Area Served
Table 21. Global Key Players of New Chemical Entities (NCE), Products and Applications
Table 22. Global Key Players of New Chemical Entities (NCE), Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global New Chemical Entities (NCE) Market Size by Type (US$ Million), 2021–2026
Table 25. Global New Chemical Entities (NCE) Revenue Market Share by Type (2021–2026)
Table 26. Global New Chemical Entities (NCE) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global New Chemical Entities (NCE) Revenue Market Share by Type (2027–2032)
Table 28. Global New Chemical Entities (NCE) Market Size by Application (US$ Million), 2021–2026
Table 29. Global New Chemical Entities (NCE) Revenue Market Share by Application (2021–2026)
Table 30. Global New Chemical Entities (NCE) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global New Chemical Entities (NCE) Revenue Market Share by Application (2027–2032)
Table 32. North America New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America New Chemical Entities (NCE) Market Size by Country (US$ Million), 2021–2026
Table 34. North America New Chemical Entities (NCE) Market Size by Country (US$ Million), 2027–2032
Table 35. Europe New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe New Chemical Entities (NCE) Market Size by Country (US$ Million), 2021–2026
Table 37. Europe New Chemical Entities (NCE) Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific New Chemical Entities (NCE) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific New Chemical Entities (NCE) Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific New Chemical Entities (NCE) Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America New Chemical Entities (NCE) Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America New Chemical Entities (NCE) Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa New Chemical Entities (NCE) Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa New Chemical Entities (NCE) Market Size by Country (US$ Million), 2027–2032
Table 47. KATSURA CHEMICAL CO., LTD Company Details
Table 48. KATSURA CHEMICAL CO., LTD Business Overview
Table 49. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) Product
Table 50. KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 51. KATSURA CHEMICAL CO., LTD Recent Development
Table 52. NMS Group (Accelera Srl) Company Details
Table 53. NMS Group (Accelera Srl) Business Overview
Table 54. NMS Group (Accelera Srl) New Chemical Entities (NCE) Product
Table 55. NMS Group (Accelera Srl) Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 56. NMS Group (Accelera Srl) Recent Development
Table 57. Adragos Pharma Company Details
Table 58. Adragos Pharma Business Overview
Table 59. Adragos Pharma New Chemical Entities (NCE) Product
Table 60. Adragos Pharma Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 61. Adragos Pharma Recent Development
Table 62. Syngene Company Details
Table 63. Syngene Business Overview
Table 64. Syngene New Chemical Entities (NCE) Product
Table 65. Syngene Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 66. Syngene Recent Development
Table 67. Regis Custom API Company Details
Table 68. Regis Custom API Business Overview
Table 69. Regis Custom API New Chemical Entities (NCE) Product
Table 70. Regis Custom API Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 71. Regis Custom API Recent Development
Table 72. Bachem Company Details
Table 73. Bachem Business Overview
Table 74. Bachem New Chemical Entities (NCE) Product
Table 75. Bachem Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 76. Bachem Recent Development
Table 77. Suven Pharma Company Details
Table 78. Suven Pharma Business Overview
Table 79. Suven Pharma New Chemical Entities (NCE) Product
Table 80. Suven Pharma Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 81. Suven Pharma Recent Development
Table 82. Aspen API Company Details
Table 83. Aspen API Business Overview
Table 84. Aspen API New Chemical Entities (NCE) Product
Table 85. Aspen API Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 86. Aspen API Recent Development
Table 87. MedPharm Company Details
Table 88. MedPharm Business Overview
Table 89. MedPharm New Chemical Entities (NCE) Product
Table 90. MedPharm Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 91. MedPharm Recent Development
Table 92. Intertek Company Details
Table 93. Intertek Business Overview
Table 94. Intertek New Chemical Entities (NCE) Product
Table 95. Intertek Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 96. Intertek Recent Development
Table 97. Neuland Laboratories Company Details
Table 98. Neuland Laboratories Business Overview
Table 99. Neuland Laboratories New Chemical Entities (NCE) Product
Table 100. Neuland Laboratories Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 101. Neuland Laboratories Recent Development
Table 102. Piramal Pharma Solutions Company Details
Table 103. Piramal Pharma Solutions Business Overview
Table 104. Piramal Pharma Solutions New Chemical Entities (NCE) Product
Table 105. Piramal Pharma Solutions Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 106. Piramal Pharma Solutions Recent Development
Table 107. Sai Life Sciences Company Details
Table 108. Sai Life Sciences Business Overview
Table 109. Sai Life Sciences New Chemical Entities (NCE) Product
Table 110. Sai Life Sciences Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 111. Sai Life Sciences Recent Development
Table 112. Chempro Pharma Company Details
Table 113. Chempro Pharma Business Overview
Table 114. Chempro Pharma New Chemical Entities (NCE) Product
Table 115. Chempro Pharma Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 116. Chempro Pharma Recent Development
Table 117. LG Chem Company Details
Table 118. LG Chem Business Overview
Table 119. LG Chem New Chemical Entities (NCE) Product
Table 120. LG Chem Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 121. LG Chem Recent Development
Table 122. Sofpromed Company Details
Table 123. Sofpromed Business Overview
Table 124. Sofpromed New Chemical Entities (NCE) Product
Table 125. Sofpromed Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 126. Sofpromed Recent Development
Table 127. Aurigene Pharmaceutical Services Ltd. Company Details
Table 128. Aurigene Pharmaceutical Services Ltd. Business Overview
Table 129. Aurigene Pharmaceutical Services Ltd. New Chemical Entities (NCE) Product
Table 130. Aurigene Pharmaceutical Services Ltd. Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 131. Aurigene Pharmaceutical Services Ltd. Recent Development
Table 132. Aragen Life Sciences Ltd Company Details
Table 133. Aragen Life Sciences Ltd Business Overview
Table 134. Aragen Life Sciences Ltd New Chemical Entities (NCE) Product
Table 135. Aragen Life Sciences Ltd Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 136. Aragen Life Sciences Ltd Recent Development
Table 137. WuXi AppTec Company Details
Table 138. WuXi AppTec Business Overview
Table 139. WuXi AppTec New Chemical Entities (NCE) Product
Table 140. WuXi AppTec Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 141. WuXi AppTec Recent Development
Table 142. PharmaBlock Sciences Nanjing Inc Company Details
Table 143. PharmaBlock Sciences Nanjing Inc Business Overview
Table 144. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) Product
Table 145. PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
Table 146. PharmaBlock Sciences Nanjing Inc Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. New Chemical Entities (NCE) Picture
Figure 2. Global New Chemical Entities (NCE) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global New Chemical Entities (NCE) Market Share by Type: 2025 vs 2032
Figure 4. NCE Discovery Features
Figure 5. Drug Formulation Development Features
Figure 6. Large-scale Manufacturing Features
Figure 7. Global New Chemical Entities (NCE) Market Size by Application (US$ Million), 2021–2032
Figure 8. Global New Chemical Entities (NCE) Market Share by Application: 2025 vs 2032
Figure 9. Tumors Case Studies
Figure 10. Cardiovascular Diseases Case Studies
Figure 11. Other Case Studies
Figure 12. New Chemical Entities (NCE) Report Years Considered
Figure 13. Global New Chemical Entities (NCE) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global New Chemical Entities (NCE) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global New Chemical Entities (NCE) Market Share by Region: 2025 vs 2032
Figure 16. Global New Chemical Entities (NCE) Market Share by Players in 2025
Figure 17. Global New Chemical Entities (NCE) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by New Chemical Entities (NCE) Revenue in 2025
Figure 19. North America New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America New Chemical Entities (NCE) Market Share by Country (2021–2032)
Figure 21. United States New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe New Chemical Entities (NCE) Market Share by Country (2021–2032)
Figure 25. Germany New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific New Chemical Entities (NCE) Market Share by Region (2021–2032)
Figure 33. China New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America New Chemical Entities (NCE) Market Share by Country (2021–2032)
Figure 41. Mexico New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa New Chemical Entities (NCE) Market Share by Country (2021–2032)
Figure 45. Israel New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. KATSURA CHEMICAL CO., LTD Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 49. NMS Group (Accelera Srl) Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 50. Adragos Pharma Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 51. Syngene Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 52. Regis Custom API Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 53. Bachem Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 54. Suven Pharma Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 55. Aspen API Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 56. MedPharm Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 57. Intertek Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 58. Neuland Laboratories Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 59. Piramal Pharma Solutions Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 60. Sai Life Sciences Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 61. Chempro Pharma Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 62. LG Chem Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 63. Sofpromed Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 64. Aurigene Pharmaceutical Services Ltd. Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 65. Aragen Life Sciences Ltd Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 66. WuXi AppTec Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 67. PharmaBlock Sciences Nanjing Inc Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
